MPM joins the his­toric SPAC boom as its blank check com­pa­ny files for an IPO

An­oth­er blank check com­pa­ny has filed to ride the biotech IPO wave, which shows no sign of crash­ing any­time soon.

Turmer­ic Ac­qui­si­tion, a spe­cial pur­pose ac­qui­si­tion com­pa­ny formed by Boston-based MPM Cap­i­tal, an­nounced on Mon­day that it’s look­ing for a $100 mil­lion raise. It will be one of sev­er­al to hit Nas­daq in a his­toric year for SPACs. It’s not clear which biotechs are in Tumer­ic’s sights — but it says it’s go­ing af­ter in­no­v­a­tive com­pa­nies with “new modal­i­ties”.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER